Dynamic frailty-tailored therapy (DynaFiT): A proof-of-concept study in elderly patients with newly diagnosed multiple myeloma

被引:0
|
作者
Dai, Yun [1 ]
Jin, Fengyan [2 ]
机构
[1] First Hosp Jilin Univ, Lab Canc Precis Med, 519 Dongminzhu St, Changchun 130061, Jilin, Peoples R China
[2] First Hosp Jilin Univ, Dept Hematol, 71 Xinmin St, Changchun 130012, Jilin, Peoples R China
来源
BLOOD SCIENCE | 2024年 / 6卷 / 04期
基金
中国国家自然科学基金;
关键词
DARATUMUMAB;
D O I
10.1097/BS9.0000000000000208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (05) : 679 - 686
  • [42] Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    FUTURE ONCOLOGY, 2015, 11 (11) : 1643 - 1658
  • [43] Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Nomura-Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 91 - 95
  • [44] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
  • [45] Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma
    Moreau, Philippe
    Giralt, Sergio A.
    LEUKEMIA RESEARCH, 2012, 36 : S13 - S18
  • [46] Analysis of compression fractures in patients with newly diagnosed multiple myeloma on comprehensive therapy
    Angtuaco, EJ
    Justus, M
    Sethi, R
    Erdem, E
    Van Hemert, RL
    Stringer, WA
    RADIOLOGY, 2001, 221 : 138 - 138
  • [47] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Meletios A Dimopoulos
    Efstathios Kastritis
    Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
  • [48] Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma
    Forsberg, Peter A.
    Rossi, Adriana C.
    Boyer, Angelique
    Tegnestam, Linda
    Pearse, Roger N.
    Perry, Arthur
    Pekle, Karen A.
    Jayabalan, David
    Ely, Scott
    Boussi, Leora
    Sherbenou, Daniel W.
    Willianns, Colt
    Allan, John N.
    Coleman, Morton
    Niesvizky, Ruben
    Mark, Tomer M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (05) : 539 - 545
  • [49] BORTEZOMIB, MELPHALAN AND DEXAMETHASONE (VM-DEX) IS A SAFE AND EFFECTIVE THERAPY FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Gozzetti, A.
    Defina, M.
    Bocchia, M.
    Fabbri, A.
    Marchini, E.
    Chitarrelli, I.
    Lauria, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 589 - 589
  • [50] Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
    Garderet, Laurent
    Beohou, Eric
    Caillot, Denis
    Stoppa, Anne Marie
    Touzeau, Cyrille
    Chretien, Marie Lorraine
    Karlin, Lionel
    Moreau, Philippe
    Fontan, Jean
    Blaise, Didier
    Polge, Emmanuelle
    Gueye, Mor Seny
    Ikhlef, Souhila
    Marjanovic, Zora
    Labopin, Myriam
    Mohty, Mohamad
    HAEMATOLOGICA, 2016, 101 (11) : 1390 - 1397